PTPRZ1 and central nervous system cancer: We recently examined the fusion landscape of WHO-grade II-IV glioma patients using RNA sequencing analysis, 214 fusion transcripts in 272 glioma patients were identified, and revealed a novel PTPRZ1-MET fusion transcript in secondary GBMs (sGBMs) [19].